Mujtaba Husain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mujtaba Husain has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Anthony S. David
Division of Psychiatry, UCL Institute of Mental Health, Maple House, 149 Tottenham Court Road, Maple House, London W1T 7NF, UK
1 shared publicationBarbara A. Crothers
Divisions of Gynecology and Breast Pathology and Cytopathology, Joint Pathology Center, Silver Spring, Maryland
1 shared publicationBenjamin L. Witt
Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah
1 shared publicationChengquan Zhao
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
1 shared publicationDaniel F.I. Kurtycz
Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
1 shared publicationDiane Davis Davey
Department of Clinical Sciences, University of Central Florida College of Medicine, Orlando, Florida
1 shared publication
Latest Publications
- 1 March 2022
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 11 (2) , 102-113
Performance of specific morphologic features in distinguishing low-grade squamous intraepithelial lesions from high-grade squamous intraepithelial lesions in borderline cases: a College of American Pathologists Cytopathology Committee multiobserver study
- 1 March 2022
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 11 (2) , 102-113
Performance of specific morphologic features in distinguishing low-grade squamous intraepithelial lesions from high-grade squamous intraepithelial lesions in borderline cases: a College of American Pathologists Cytopathology Committee multiobserver study
- 7 September 2021
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 53 (7) , 3232-3233
PRINCE Secondary: transdiagnostic cognitive behaviour therapy for persistent physical symptoms
- 7 September 2021
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 53 (7) , 3232-3233
PRINCE Secondary: transdiagnostic cognitive behaviour therapy for persistent physical symptoms
- 1 January 2008
- Published by S. Karger AG in Acta Cytologica
- Vol. 52 (4) , 434-438
Significance of High-Risk Human Papillomavirus DNA–Positive Atypical Squamous Cells of Undetermined Significance Pap Smears in Perimenopausal and Postmenopausal Women
To determine the risk of high-grade squamous intraepithelial lesion (HSIL)/cervical intraepithelial neoplasia (CIN) 2 or 3 in perimenopausal and postmenopausal women with high-risk human papillomavirus (HPV) DNA-positive atypical squamous cells of undetermined significance (ASCUS) on Pap tests. A total of 752 perimenopausal and postmenopausal women (patients 45 years) with an ASCUS interpretation on ThinPrep Pap tests were identified in 2002 and 2003. High risk HPVDNA was detected in 191 (25.4%) women. The follow-up results in these 136 women were compared with those of women <45 years. Of the 136 perimenopausal and postmenopausal women, 64.7% became negative on cytology or biopsy and 30.9% revealed persistent low-grade SIL (LSIL)/CIN 1. Furthermore, 5 women (3.68%) were diagnosed with HSIL/CIN 2 or 3, and 1 patient had squamous cell carcinoma (0.74%). The rate of HSIL/CIN 2 or 3 or worse detected in perimenopausal and postmenopausal women was significant lower than 10.6% in women <45 years (p = 0.028). Our study showed that perimenopausal and postmenopausal women with high-risk HPV positivity and an ASCUS interpretation have a significantly lower risk of HSIL/CIN 2 or 3 detected. Nonetheless, the risk of a significant finding on workup, including invasive carcinoma, indicates the need for colposcopic evaluation of these women.
- 1 January 2008
- Published by S. Karger AG in Acta Cytologica
- Vol. 52 (4) , 434-438
Significance of High-Risk Human Papillomavirus DNA–Positive Atypical Squamous Cells of Undetermined Significance Pap Smears in Perimenopausal and Postmenopausal Women
To determine the risk of high-grade squamous intraepithelial lesion (HSIL)/cervical intraepithelial neoplasia (CIN) 2 or 3 in perimenopausal and postmenopausal women with high-risk human papillomavirus (HPV) DNA-positive atypical squamous cells of undetermined significance (ASCUS) on Pap tests. A total of 752 perimenopausal and postmenopausal women (patients 45 years) with an ASCUS interpretation on ThinPrep Pap tests were identified in 2002 and 2003. High risk HPVDNA was detected in 191 (25.4%) women. The follow-up results in these 136 women were compared with those of women <45 years. Of the 136 perimenopausal and postmenopausal women, 64.7% became negative on cytology or biopsy and 30.9% revealed persistent low-grade SIL (LSIL)/CIN 1. Furthermore, 5 women (3.68%) were diagnosed with HSIL/CIN 2 or 3, and 1 patient had squamous cell carcinoma (0.74%). The rate of HSIL/CIN 2 or 3 or worse detected in perimenopausal and postmenopausal women was significant lower than 10.6% in women <45 years (p = 0.028). Our study showed that perimenopausal and postmenopausal women with high-risk HPV positivity and an ASCUS interpretation have a significantly lower risk of HSIL/CIN 2 or 3 detected. Nonetheless, the risk of a significant finding on workup, including invasive carcinoma, indicates the need for colposcopic evaluation of these women.